✦ LIBER ✦

PCN95 A MARKOV MODEL TO ESTIMATE THE COST-EFFECTIVENESS OF OMACETAXINE IN CHRONIC MYELOID LEUKEMIA

✍ Scribed by NJ Brereton; AJ Batty; CF Foy; AL McCormick

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN14 THE COST AND COST EFFECTIVENESS OF

✍ Juarez-Garcia, A; Uc-Coyoc, R; Hernandez-Rivera, G; Rangel, S; Taylor, MJ; Lital 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PCN93 COST-EFFECTIVENESS ANALYSIS OF BEN

✍ J Malin; T Kongnakorn; J Sterchele; C Salvador; D Getsios; M Mwamburi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PSS18 COST-EFFECTIVENESS OF THE BIOLOGIC

✍ LD Goldberg; SR Feldman; TS Marshall; E Jaracz 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

PCN15 ESTIMATING THE COST EFFECTIVENESS

✍ S Redmond; N Demarteau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN150 SYSTEMATIC LITERATURE REVIEW ON T

✍ M Ratcliffe; PE Hudson; D Ossa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCN92 Cost-Effectiveness of Nilotinib Ve

✍ R. Yagudina; A. Kulikov; I. Komarov 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB